| Updated on March 13, 2018

Sub.: Clarification / Information on news item With reference to your e-mail dated 10-Apr-17, referring to the news item appeared in The Economic Times on 08-Apr-17 titled Torrent close to buying women healthcare portfolio of Swiss pharma major Novartis, we hereby submit our response as follows: The Company had executed certain agreements (Agreement) with Novartis AG, Basel, Switzerland and its Affiliate to acquire certain generic pharmaceutical products. The closure of the deal is subject to the approval of Competition Commission of India (CCI) and other applicable regulatory approvals. As the arrangement was not of material nature, the disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 (Listing Regulations) was not required. As a responsible listed organisation, we do inform the Exchanges of all information which are required to be disclosed, on timely basis, in the terms of Listing Regulations and will continue to do so.

Pdf Link: Updates

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 11, 2017
This article is closed for comments.
Please Email the Editor